Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 14, 2005; 11(46): 7242-7247
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7242
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7242
Table 2 Colon tumor incidence, classification, multiplicity, tumor volume, and stage in rats treated with DMH with or without endostatin (mean±SD)
Treatment | Incidence | Adenoma | Carcinoma | Multiplicity | Tumor volume | Duke's stage | |||
n | n (%) | n (%) | n (%) | number | mm3 | A | B | C | |
DMH+endostatin | 10 | 10(100) | 5 (50) | 5 (50) | 2.50±1.80 | 2.35±1.84 | 1 | 4 | -a |
DMH+L lactis | 10 | 9(90) | 2 (22) | 7 (78) | 2.67±1.47 | 2.54±2.00 | 4 | 6 | -a |
DMH | 10 | 10 (100) | 5 (50) | 5 (50) | 4.00±2.96 | 4.31±4.56 | 2 | - | 3 |
-
Citation: Li W, Li CB. Effect of oral
Lactococcus lactis containing endostatin on 1, 2-dimethylhydrazine-induced colon tumor in rats. World J Gastroenterol 2005; 11(46): 7242-7247 - URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7242.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i46.7242